{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:11Z","timestamp":1792725191649,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10787-025-01996-4","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:36:00Z","timestamp":1759559760000},"page":"6507-6534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inflammation and immune biomarkers: new frontiers in understanding and managing diabetes complications"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3280-919X","authenticated-orcid":false,"given":"Polu Picheswara","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malakapogu Ravindra","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"1996_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/S00210-025-03980-9","author":"AR Abdullah","year":"2025","unstructured":"Abdullah AR, Seliem MA, Khidr EG et al (2025) A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/S00210-025-03980-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1996_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/13813455.2020.1837183","volume":"129","author":"KM Adki","year":"2023","unstructured":"Adki KM, Kulkarni YA (2023) Biomarkers in diabetic neuropathy. Arch Physiol Biochem 129:460\u2013475. https:\/\/doi.org\/10.1080\/13813455.2020.1837183","journal-title":"Arch Physiol Biochem"},{"issue":"4","key":"1996_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-023-00429-z","volume":"41","author":"A Ahmad","year":"2024","unstructured":"Ahmad A, Lim LL, Morieri ML et al (2024) Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis. Commun Med 41(4):1\u201328. https:\/\/doi.org\/10.1038\/s43856-023-00429-z","journal-title":"Commun Med"},{"key":"1996_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/J.CCA.2021.09.003","volume":"523","author":"A Al Mamun","year":"2021","unstructured":"Al Mamun A, Ara Mimi A, Wu Y et al (2021) Pyroptosis in diabetic nephropathy. Clin Chim Acta 523:131\u2013143. https:\/\/doi.org\/10.1016\/J.CCA.2021.09.003","journal-title":"Clin Chim Acta"},{"key":"1996_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJNURSTU.2024.104747","author":"H Aldahmashi","year":"2024","unstructured":"Aldahmashi H, Maneze D, Molloy L, Salamonson Y (2024) Nurses\u2019 adoption of diabetes clinical practice guidelines in primary care and the impacts on patient outcomes and safety: an integrative review. Int J Nurs Stud. https:\/\/doi.org\/10.1016\/J.IJNURSTU.2024.104747","journal-title":"Int J Nurs Stud"},{"key":"1996_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/NU9121310","author":"A Alkhatib","year":"2017","unstructured":"Alkhatib A, Tsang C, Tiss A et al (2017) Functional foods and lifestyle approaches for diabetes prevention and management. Nutrients. https:\/\/doi.org\/10.3390\/NU9121310","journal-title":"Nutrients"},{"key":"1996_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.REDOX.2020.101517","volume":"34","author":"N Apostolova","year":"2020","unstructured":"Apostolova N, Iannantuoni F, Gruevska A et al (2020) Mechanisms of action of metformin in type 2 diabetes: effects on mitochondria and leukocyte\u2013endothelium interactions. Redox Biol 34:101517. https:\/\/doi.org\/10.1016\/J.REDOX.2020.101517","journal-title":"Redox Biol"},{"key":"1996_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.34171\/MJIRI.34.5","volume":"34","author":"H Bashir","year":"2020","unstructured":"Bashir H, Bhat SA, Majid S et al (2020) Role of inflammatory mediators (TNF-\u03b1, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir India. Med J Islam Repub Iran 34:5. https:\/\/doi.org\/10.34171\/MJIRI.34.5","journal-title":"Med J Islam Repub Iran"},{"key":"1996_CR9","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1111\/DOM.16242","volume":"27","author":"M Bellemare","year":"2025","unstructured":"Bellemare M, Bourcier L, Iglesies-Grau J et al (2025) Mechanisms of diabetic cardiomyopathy: focus on inflammation. Diabetes Obes Metab 27:2326\u20132338. https:\/\/doi.org\/10.1111\/DOM.16242","journal-title":"Diabetes Obes Metab"},{"key":"1996_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-025-05818-Z","author":"E Cecerska-Hery\u0107","year":"2025","unstructured":"Cecerska-Hery\u0107 E, Engwert W, Micha\u0142\u00f3w J et al (2025) Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-025-05818-Z","journal-title":"Sci Rep"},{"key":"1996_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/BIOLOGY10010018","volume":"10","author":"A Charlton","year":"2020","unstructured":"Charlton A, Garzarella J, Jandeleit-Dahm KAM, Jha JC (2020) Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology 10:18. https:\/\/doi.org\/10.3390\/BIOLOGY10010018","journal-title":"Biology"},{"key":"1996_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2337\/DCI20-0022","volume":"43","author":"WK Chung","year":"2020","unstructured":"Chung WK, Erion K, Florez JC et al (2020) Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43:1617\u20131635. https:\/\/doi.org\/10.2337\/DCI20-0022","journal-title":"Diabetes Care"},{"key":"1996_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/NU16040507","volume":"16","author":"A Dama","year":"2024","unstructured":"Dama A, Shpati K, Daliu P et al (2024) Targeting metabolic diseases: the role of nutraceuticals in modulating oxidative stress and inflammation. Nutrients 16:507. https:\/\/doi.org\/10.3390\/NU16040507","journal-title":"Nutrients"},{"key":"1996_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/DMSO.S100074","volume":"10","author":"B Dorcely","year":"2017","unstructured":"Dorcely B, Katz K, Jagannathan R et al (2017) Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab Syndr Obes Targets Ther 10:345. https:\/\/doi.org\/10.2147\/DMSO.S100074","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"1996_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3390\/BIOMEDICINES11041120","volume":"11","author":"JF dos Santos Haber","year":"2023","unstructured":"dos Santos Haber JF, Barbalho SM, Sgarbi JA et al (2023) The relationship between type 1 diabetes mellitus, TNF-\u03b1, and IL-10 gene expression. Biomed 11:1120. https:\/\/doi.org\/10.3390\/BIOMEDICINES11041120","journal-title":"Biomed"},{"key":"1996_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2337\/CD25-AINT","volume":"43","author":"N ElSayed","year":"2025","unstructured":"ElSayed N, Baig A, Balapattabi K et al (2025) Standards of care in diabetes\u20142025 abridged for primary care. Clin Diabetes 43:182. https:\/\/doi.org\/10.2337\/CD25-AINT","journal-title":"Clin Diabetes"},{"key":"1996_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-020-02229-5\/TABLES\/4","volume":"22","author":"MC Genovese","year":"2020","unstructured":"Genovese MC, Burmester GR, Hagino O et al (2020) Interleukin-6 receptor blockade or TNF\u03b1 inhibition for reducing glycaemia in patients with RA and diabetes: Post hoc analyses of three randomised, controlled trials. Arthritis Res Ther 22:1\u201312. https:\/\/doi.org\/10.1186\/S13075-020-02229-5\/TABLES\/4","journal-title":"Arthritis Res Ther"},{"key":"1996_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CELLS10020314","volume":"10","author":"IM Gora","year":"2021","unstructured":"Gora IM, Ciechanowska A, Ladyzynski P (2021) Nlrp3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes. Cells 10:1\u201329. https:\/\/doi.org\/10.3390\/CELLS10020314","journal-title":"Cells"},{"key":"1996_CR19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3390\/BIOMEDICINES10030666","volume":"10","author":"M Grau","year":"2022","unstructured":"Grau M, Matsumori A (2022) Novel biomarkers of inflammation for the management of diabetes: immunoglobulin-free light chains. Biomed 10:666. https:\/\/doi.org\/10.3390\/BIOMEDICINES10030666","journal-title":"Biomed"},{"key":"1996_CR20","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2337\/DCI24-0001","volume":"47","author":"JB Green","year":"2024","unstructured":"Green JB, Crowley MJ, Thirunavukkarasu S et al (2024) The final frontier in Diabetes care: implementing research in real-world practice Diabetes care. Diabetes Care 47:1299\u20131310. https:\/\/doi.org\/10.2337\/DCI24-0001","journal-title":"Diabetes Care"},{"key":"1996_CR21","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","volume":"401","author":"EW Gregg","year":"2023","unstructured":"Gregg EW, Buckley J, Ali MK et al (2023) Improving Health Outcomes of People with Diabetes Mellitus: Global Target Setting to Reduce the Burden of Diabetes Mellitus by 2030. Lancet (London, England) 401:1302. https:\/\/doi.org\/10.1016\/S0140-6736(23)00001-6","journal-title":"Lancet (London, England)"},{"key":"1996_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/OBR.13818","volume":"25","author":"R Gui","year":"2024","unstructured":"Gui R, Ren Y, Wang Z et al (2024) Deciphering interleukin-18 in diabetes and its complications: Biological features, mechanisms, and therapeutic perspectives. Obes Rev 25:e13818. https:\/\/doi.org\/10.1111\/OBR.13818","journal-title":"Obes Rev"},{"key":"1996_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12872-025-04916-0\/TABLES\/7","volume":"25","author":"J Guo","year":"2025","unstructured":"Guo J, Zhang Z (2025) Novel biomarker panel combined with imaging parameters for predicting cardiovascular complications in diabetic patients: a retrospective cohort study. BMC Cardiovasc Disord 25:1\u201311. https:\/\/doi.org\/10.1186\/S12872-025-04916-0\/TABLES\/7","journal-title":"BMC Cardiovasc Disord"},{"key":"1996_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231167853","volume":"18","author":"T Haregu","year":"2023","unstructured":"Haregu T, Delobelle P, Issaka A et al (2023) Digital health solutions for community-based control of diabetes during COVID-19 pandemic: a scoping review of implementation outcomes. J Diabetes Sci Technol 18:1480. https:\/\/doi.org\/10.1177\/19322968231167853","journal-title":"J Diabetes Sci Technol"},{"key":"1996_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.774272","author":"K Huang","year":"2022","unstructured":"Huang K, Liang Y, Ma Y et al (2022) The variation and correlation of serum adiponectin, nesfatin-1, IL-6, and TNF-\u03b1 levels in prediabetes. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/FENDO.2022.774272","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/S41420-023-01553-4","author":"JL Huo","year":"2023","unstructured":"Huo JL, Feng Q, Pan S et al (2023) Diabetic cardiomyopathy: early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions. Cell Death Discov. https:\/\/doi.org\/10.1038\/S41420-023-01553-4","journal-title":"Cell Death Discov"},{"key":"1996_CR27","first-page":"1365","volume":"29","author":"A Ibrahim","year":"2022","unstructured":"Ibrahim A, Altamim Z, Abed A et al (2022) Quality assurance in clinical laboratories: best practices and continuous improvement strategies. J Popul Ther Clin Pharmacol 29:1365\u20131374","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"1996_CR28","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.biopha.2018.09.058","volume":"108","author":"OM Ighodaro","year":"2018","unstructured":"Ighodaro OM (2018) Molecular pathways associated with oxidative stress in diabetes mellitus. Biomed Pharmacother 108:656\u2013662. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.058","journal-title":"Biomed Pharmacother"},{"key":"1996_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12051098","volume":"12","author":"R Jha","year":"2024","unstructured":"Jha R, Lopez-Trevino S, Kankanamalage HR et al (2024) Diabetes and renal complications: an overview on pathophysiology, biomarkers and therapeutic interventions. Biomedicines 12:1098. https:\/\/doi.org\/10.3390\/BIOMEDICINES12051098","journal-title":"Biomedicines"},{"key":"1996_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/JCM14134606","volume":"14","author":"K Karamitsos","year":"2025","unstructured":"Karamitsos K, Oikonomou E, Theofilis P et al (2025) The role of NLRP3 inflammasome in type 2 diabetes mellitus and its macrovascular complications. J Clin Med 14:4606. https:\/\/doi.org\/10.3390\/JCM14134606","journal-title":"J Clin Med"},{"key":"1996_CR31","doi-asserted-by":"publisher","DOI":"10.21037\/ATM.2019.02.34","volume":"7","author":"CE Kosmas","year":"2019","unstructured":"Kosmas CE, Silverio D, Sourlas A et al (2019) Anti-inflammatory therapy for cardiovascular disease. Ann Transl Med 7:147\u2013147. https:\/\/doi.org\/10.21037\/ATM.2019.02.34","journal-title":"Ann Transl Med"},{"key":"1996_CR32","doi-asserted-by":"publisher","DOI":"10.7759\/CUREUS.56674","volume":"16","author":"A Kulkarni","year":"2024","unstructured":"Kulkarni A, Thool AR, Daigavane S (2024) Understanding the clinical relationship between diabetic retinopathy, nephropathy, and neuropathy: a comprehensive review. Cureus 16:e56674. https:\/\/doi.org\/10.7759\/CUREUS.56674","journal-title":"Cureus"},{"key":"1996_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/DOM.15991","volume":"27","author":"TN Le","year":"2025","unstructured":"Le TN, Bright R, Truong VK et al (2025) Key biomarkers in type 2 diabetes patients: a systematic review. Diabetes Obes Metab 27:7\u201322. https:\/\/doi.org\/10.1111\/DOM.15991","journal-title":"Diabetes Obes Metab"},{"key":"1996_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/DMJ.2021.0280","volume":"46","author":"SH Lee","year":"2021","unstructured":"Lee SH, Park SY, Choi CS (2021) Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J 46:15\u201337. https:\/\/doi.org\/10.4093\/DMJ.2021.0280","journal-title":"Diabetes Metab J"},{"key":"1996_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/S41420-023-01452-8","author":"S Li","year":"2023","unstructured":"Li S, Feng L, Li G et al (2023) GSDME-dependent pyroptosis signaling pathway in diabetic nephropathy. Cell Death Discov. https:\/\/doi.org\/10.1038\/S41420-023-01452-8","journal-title":"Cell Death Discov"},{"key":"1996_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12933-025-02899-Y\/TABLES\/1","volume":"24","author":"Z Li","year":"2025","unstructured":"Li Z, Ren Y, Jiang F et al (2025) Unveiling biomarkers via plasma metabolome profiling for diabetic macrovascular and microvascular complications. Cardiovasc Diabetol 24:1\u201314. https:\/\/doi.org\/10.1186\/S12933-025-02899-Y\/TABLES\/1","journal-title":"Cardiovasc Diabetol"},{"issue":"24","key":"1996_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12933-025-02707-7","volume":"241","author":"L Luo","year":"2025","unstructured":"Luo L, Zuo Y (2025) Dai L (2025) Metabolic rewiring and inter-organ crosstalk in diabetic HFpEF. Cardiovasc Diabetol 241(24):1\u201314. https:\/\/doi.org\/10.1186\/S12933-025-02707-7","journal-title":"Cardiovasc Diabetol"},{"key":"1996_CR38","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.7150\/IJBS.59965","volume":"17","author":"X Ma","year":"2021","unstructured":"Ma X, Liu Z, Ilyas I et al (2021) GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci 17:2050. https:\/\/doi.org\/10.7150\/IJBS.59965","journal-title":"Int J Biol Sci"},{"key":"1996_CR39","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2147\/JIR.S291453","volume":"14","author":"A Mamun Al","year":"2021","unstructured":"Mamun Al A, Wu Y, Nasrin F et al (2021) Role of pyroptosis in diabetes and its therapeutic implications. J Inflamm Res 14:2187\u20132206. https:\/\/doi.org\/10.2147\/JIR.S291453","journal-title":"J Inflamm Res"},{"key":"1996_CR40","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1016\/J.DSX.2016.12.021","volume":"11","author":"C Mertoglu","year":"2017","unstructured":"Mertoglu C, Gunay M (2017) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr Clin Res Rev 11:S127\u2013S131. https:\/\/doi.org\/10.1016\/J.DSX.2016.12.021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"1996_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-020-77914-1","author":"R Mohallem","year":"2020","unstructured":"Mohallem R, Aryal UK (2020) Regulators of TNF\u03b1 mediated insulin resistance elucidated by quantitative proteomics. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-020-77914-1","journal-title":"Sci Rep"},{"key":"1996_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/JCM12186022","author":"IM Ni\u021bulescu","year":"2023","unstructured":"Ni\u021bulescu IM, Ciulei G, Cozma A et al (2023) From innate immunity to metabolic disorder: a review of the NLRP3 inflammasome in diabetes mellitus. J Clin Med. https:\/\/doi.org\/10.3390\/JCM12186022","journal-title":"J Clin Med"},{"issue":"36","key":"1996_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S43162-024-00375-9","volume":"361","author":"SO Olalekan","year":"2024","unstructured":"Olalekan SO, Bakare OO, Okwute PG et al (2024) The role of nutraceuticals in managing metabolic syndrome: a review of clinical studies. Egypt J Intern Med 361(36):1\u201315. https:\/\/doi.org\/10.1186\/S43162-024-00375-9","journal-title":"Egypt J Intern Med"},{"key":"1996_CR44","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/JPEM-2024-0043","volume":"37","author":"S Ozde","year":"2024","unstructured":"Ozde S, Akture G, Ozel MA et al (2024) Evaluation of the systemic-immune inflammation index (SII) and systemic immune-inflammation response index (SIRI) in children with type 1 diabetes mellitus and its relationship with cumulative glycemic exposure. J Pediatr Endocrinol Metab 37:635\u2013643. https:\/\/doi.org\/10.1515\/JPEM-2024-0043","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1996_CR45","doi-asserted-by":"publisher","first-page":"S244","DOI":"10.2337\/DCS15-3015","volume":"39","author":"RM Pollack","year":"2016","unstructured":"Pollack RM, Donath MY, LeRoith D, Leibowitz G (2016) Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care 39:S244\u2013S252. https:\/\/doi.org\/10.2337\/DCS15-3015","journal-title":"Diabetes Care"},{"key":"1996_CR46","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1007\/S10787-024-01571-3","volume":"32","author":"PT Roshni","year":"2024","unstructured":"Roshni PT, Rekha PD (2024) Essential oils: a potential alternative with promising active ingredients for pharmaceutical formulations in chronic wound management. Inflammopharmacology 32:3611\u20133630. https:\/\/doi.org\/10.1007\/S10787-024-01571-3","journal-title":"Inflammopharmacology"},{"key":"1996_CR47","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/IJMS26041670","volume":"26","author":"EY Rykova","year":"2025","unstructured":"Rykova EY, Klimontov VV, Shmakova E et al (2025) Anti-inflammatory effects of SGLT2 inhibitors: focus on macrophages. Int J Mol Sci 26:1670. https:\/\/doi.org\/10.3390\/IJMS26041670","journal-title":"Int J Mol Sci"},{"key":"1996_CR48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/S40200-021-00734-1","volume":"20","author":"M Sai Laxmi","year":"2021","unstructured":"Sai Laxmi M, Prabhakar O (2021) Inflammatory biomarkers as a part of diagnosis in diabetic peripheral neuropathy. J Diabetes Metab Disord 20:869. https:\/\/doi.org\/10.1007\/S40200-021-00734-1","journal-title":"J Diabetes Metab Disord"},{"key":"1996_CR49","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/S00125-022-05731-4","volume":"65","author":"C Schiborn","year":"2022","unstructured":"Schiborn C, Schulze MB (2022) Precision prognostics for the development of complications in diabetes. Diabetologia 65:1867\u20131882. https:\/\/doi.org\/10.1007\/S00125-022-05731-4","journal-title":"Diabetologia"},{"key":"1996_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/15347346211057742","volume":"23","author":"D Serban","year":"2024","unstructured":"Serban D, Papanas N, Dascalu AM et al (2024) Significance of neutrophil to lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in diabetic foot ulcer and potential new therapeutic targets. Int J Low Extrem Wounds 23:205\u2013216. https:\/\/doi.org\/10.1177\/15347346211057742","journal-title":"Int J Low Extrem Wounds"},{"key":"1996_CR51","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.3390\/MEDICINA61081433","volume":"61","author":"D Sergi","year":"2025","unstructured":"Sergi D, Cosma-L\u0103zuran R, Leucuta D-C, Popoviciu M-S (2025) Systemic immune-inflammation index and related hematologic markers as prognostic tools in type 2 diabetes. Med 61:1433. https:\/\/doi.org\/10.3390\/MEDICINA61081433","journal-title":"Med"},{"key":"1996_CR52","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1007\/S10787-024-01557-1","volume":"32","author":"V Sharma","year":"2024","unstructured":"Sharma V, Sharma P, Singh TG (2024) Leukotriene signaling in neurodegeneration: implications for treatment strategies. Inflammopharmacology 32:3571\u20133584. https:\/\/doi.org\/10.1007\/S10787-024-01557-1","journal-title":"Inflammopharmacology"},{"key":"1996_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","volume":"12","author":"B Sheng","year":"2024","unstructured":"Sheng B, Pushpanathan K, Guan Z et al (2024) Artificial intelligence for diabetes care: current and future prospects. Lancet Diabetes Endocrinol 12:569\u2013595. https:\/\/doi.org\/10.1016\/S2213-8587(24)00154-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1996_CR54","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/MOLECULES27030950","volume":"27","author":"A Singh","year":"2022","unstructured":"Singh A, Kukreti R, Saso L, Kukreti S (2022) Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes. Molecules 27:950. https:\/\/doi.org\/10.3390\/MOLECULES27030950","journal-title":"Molecules"},{"key":"1996_CR55","doi-asserted-by":"publisher","first-page":"1542208","DOI":"10.3389\/FENDO.2025.1542208\/XML","volume":"16","author":"M Song","year":"2025","unstructured":"Song M, Dai H, Zhou Q, Meng X (2025) The immunology of diabetic cardiomyopathy. Front Endocrinol (Lausanne) 16:1542208. https:\/\/doi.org\/10.3389\/FENDO.2025.1542208\/XML","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR56","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/S11892-003-0072-3","volume":"3","author":"P Theuma","year":"2003","unstructured":"Theuma P, Fonseca VA (2003) Inflammation and emerging risk factors in diabetes mellitus and atherosclerosis. Curr Diab Rep 3:248\u2013254. https:\/\/doi.org\/10.1007\/S11892-003-0072-3","journal-title":"Curr Diab Rep"},{"key":"1996_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.CYTO.2019.02.005","volume":"117","author":"R Tian","year":"2019","unstructured":"Tian R, Tian M, Wang L et al (2019) C-reactive protein for predicting cardiovascular and all-cause mortality in type 2 diabetic patients: a meta-analysis. Cytokine 117:59\u201364. https:\/\/doi.org\/10.1016\/J.CYTO.2019.02.005","journal-title":"Cytokine"},{"key":"1996_CR58","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1038\/S41591-023-02502-5","volume":"29","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Merino J, Ahmad A et al (2023) Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nat Med 29:2438\u20132457. https:\/\/doi.org\/10.1038\/S41591-023-02502-5","journal-title":"Nat Med"},{"key":"1996_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/S13098-020-00562-Y","author":"JR Wang","year":"2020","unstructured":"Wang JR, Chen Z, Yang K et al (2020) Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. https:\/\/doi.org\/10.1186\/S13098-020-00562-Y","journal-title":"Diabetol Metab Syndr"},{"key":"1996_CR60","doi-asserted-by":"publisher","first-page":"1564170","DOI":"10.3389\/FENDO.2025.1564170\/BIBTEX","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Liu X, Xiao Z (2025) Diagnostic accuracy of neutrophil-to-lymphocyte ratio in type 2 diabetic nephropathy: a meta-analysis. Front Endocrinol (Lausanne) 16:1564170. https:\/\/doi.org\/10.3389\/FENDO.2025.1564170\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.70014","author":"R Weinberg Sibony","year":"2024","unstructured":"Weinberg Sibony R, Segev O, Dor S, Raz I (2024) Overview of oxidative stress and inflammation in diabetes. J Diabetes. https:\/\/doi.org\/10.1111\/1753-0407.70014","journal-title":"J Diabetes"},{"key":"1996_CR62","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/S10787-024-01566-0","volume":"32","author":"J Wu","year":"2024","unstructured":"Wu J, Lv T, Liu Y et al (2024) The role of quercetin in NLRP3-associated inflammation. Inflammopharmacology 32:3585\u20133610. https:\/\/doi.org\/10.1007\/S10787-024-01566-0","journal-title":"Inflammopharmacology"},{"key":"1996_CR63","doi-asserted-by":"publisher","first-page":"1065856","DOI":"10.3389\/FENDO.2022.1065856\/XML","volume":"13","author":"Z Xie","year":"2022","unstructured":"Xie Z, Xiao X (2022) Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: recent progress and future perspectives. Front Endocrinol (Lausanne) 13:1065856. https:\/\/doi.org\/10.3389\/FENDO.2022.1065856\/XML","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1996_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13098-024-01325-9","volume":"16","author":"R Zhang","year":"2024","unstructured":"Zhang R, Xie Q, Lu X et al (2024) Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus. Diabetol Metab Syndr 16:1\u201315. https:\/\/doi.org\/10.1186\/S13098-024-01325-9","journal-title":"Diabetol Metab Syndr"},{"key":"1996_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/MCO2.516","author":"L Zhao","year":"2024","unstructured":"Zhao L, Hu H, Zhang L et al (2024) Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions. MedComm. https:\/\/doi.org\/10.1002\/MCO2.516","journal-title":"MedComm"},{"key":"1996_CR66","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/DC25-S002","volume":"48","author":"B Zhu","year":"2025","unstructured":"Zhu B (2025a) Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142025. Diabetes Care 48:S27\u2013S49. https:\/\/doi.org\/10.2337\/DC25-S002","journal-title":"Diabetes Care"},{"key":"1996_CR67","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.2337\/DC25-S004","volume":"48","author":"B Zhu","year":"2025","unstructured":"Zhu B (2025b) Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142025. Diabetes Care 48:S59\u2013S85. https:\/\/doi.org\/10.2337\/DC25-S004","journal-title":"Diabetes Care"},{"key":"1996_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-024-74642-8","author":"B Zhu","year":"2024","unstructured":"Zhu B, Liu Y, Liu W et al (2024) Association of neutrophil-to-lymphocyte ratio with all-cause and cardiovascular mortality in CVD patients with diabetes or pre-diabetes. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-024-74642-8","journal-title":"Sci Rep"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01996-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01996-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T23:03:19Z","timestamp":1763420599000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01996-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1996"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01996-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interests. There are no financial or non-financial conflicts of interest related to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to participate, and consent to publish"}}]}}